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Abstract
Background: Sepsis is a debilitating systemic disease and described as a severe and irregular systemic
inflammatory reaction syndrome (SIRS) against infection. We employed CLP (Cecal Ligation and Puncture) model in
rats to investigate anti-inflammatory and antioxidant effects of phloretin, as a natural antioxidant agent, and its
protective effect on liver tissue damage caused by sepsis.
Methods: Male Wistar albino rats were randomly divided into three groups: sham group, CLP induced sepsis group
and phloretin treated CLP group. Sepsis was induced by CLP method. 50 mmol/kg Phloretin was administered
intraperitoneally in two equal doses immediately after surgery.
Results: It was observed that blood urea nitrogen (BUN) and tumor necrosis factor alpha (TNF-α) levels were
dramatically increased in the CLP induced sepsis group (43.88 ± 1.905 mg/dl, 37.63 ± 1.92, respectively) when
compared to the sham group. Moreover, tissue Glutathione (GSH) and liver nuclear factor ĸB (NF-ĸB p65)
transcription factor values were higher in CLP induced sepsis group. This elevation was considerably reduced in the
phloretin treated CLP group. No significant differences were observed in serum creatinine and creatinine
phosphokinase levels.
Conclusions: The present study suggested that phloretin, as a natural protective agent, act against tissue damages
introduced following the experimental sepsis induced model, likely caused by free oxygen radicals.
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Background
Sepsis is a common and expensive condition especially
in the elderly, which is associated with a very high
mortality rate (40 to 60 %) [1, 2]. In spite of advances in
critical care treatment of the disease such as invasive
surgical therapy and chemotherapy, and better under-
standing of its pathophysiology, the fatal frequency has
not changed significantly over the past 35 years, even in
developed countries. Sepsis is described as a severe and
irregular systemic inflammatory reaction syndrome
(SIRS) against infection [3]. Bacterial lipopolysaccharide
endotoxins trigger macrophages and enhance the release
of pro-inflammatory cytokines, hence play a pivotal role
in the development of systemic inflammatory response.
Free oxygen radicals are among important mediators re-
sponsible for the inflammatory response. They disrupt
cell membranes by rising lipid peroxidation, inhibit ATP
synthesis in the mitochondria, and may lead to oxidative
damage to DNA and proteins [4].
The systemic inflammatory stress response such as
sepsis, septic shock, and multiple organ dysfunction syn-
dromes are conditions of severity and deterioration of
essential organ function [5, 6]. It has been documented
that a relation exists between oxidative stress and peri-
toneal sepsis [7]. Antioxidant agents might counter the
toxicity of reactive oxygen species and reactive nitrogen
species [8, 9], thus free radical ablation might be
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complementary in the clinical management of sepsis-
induced multiple organ failures [10].
Secondary plant metabolites are a vast group of chemi-
cals that are synthesized from carbohydrates, fatty acids
and amino acids [11]. Flavonoids are polyphenolic com-
pounds in a natural manner and represent one of the
most extensive ingredients in fruits, vegetables, nuts, tea
and coffee [11], as well as in herbal medicine [12]. Flavo-
noids are made up of flavones, flavonols, flavanones,
chalcones, anthocyanins, and isoflavones. Flavonoids are
well known for their role as an anti-inflammatory and
antioxidant agents and shown to have health encour-
aging, chemopreventive, and disease-preventing charac-
teristics [13, 14].
Chalcones contain 2 benzene rings which are bound
together by an unsaturated carboxyl group. They are the
secondary metabolite of plants with a chemical structure
similar to curcumin [15]. By now, chalcones proven to
have many therapeutic characteristics such as antifungal,
anti-leishmania, anti-bacterial, anti-malarial and chemo-
preventive activities, in which part of these properties
disclosed to antioxidant activity and chelating the metal-
lic ions [16, 17]. Phloretin is a dihydrogen chalcone
flavonoid which primarily extracted from apple [18].
Many studies have demonstrated the pharmacophore re-
sponsible region for the anti oxidative activity of phlore-
tin [19, 20]. However, no detailed investigation has
described the role of phloretin in sepsis induced by CLP
model. This study was designed to investigate protective
effect of phloretin against sepsis-induced oxidative organ
damage using biochemical parameters, such as nuclear
factor kappa-light-chain-enhancer of activated B cells
(NF-ĸB), tumor necrosis factor–alpha (TNF-α) and tis-
sue glutathione (GSH) levels as well as the histopatho-
logical examination of liver tissues.
Methods
Chemicals
2′, 4′, 6′, 4 Tetrahrdroxydihydrochalcone (phloretin)
was obtained from Sigma-Aldrich Company (St. Louis,
MO, USA). All solvents including ethanol, tween 80 and
DMSO were supplied by Merck Company (Darmstadt,
Germany). TNF-α assay kit were purchased from Bio-
source Europe, S.A. (Nivelles, Belgium). P65 NF-ĸB tran-
scription factor kit was obtained from Cayman chemical
(USA).
Animals
Animal experiments were carried on in the light of the
protocol of Ministry of Health & Medical Education Con-
vention for the Protection of vertebrate animals used for
experimental and other scientific goals, and the protocol
was accepted by the Ethics Committee of the Tehran
University of Medicine Sciences (TUMS), Tehran, Iran.
Male Wistar albino rats, weighing 200-250 g, were
included in the study. The rats were kept in a temperature
controlled (22 ± 1 °C) room with a 12:12 h alternating
light/dark cycle in Animal Care Center, Faculty of Phar-
macy, TUMS.
Cecal Ligation and Puncture (CLP) as a sepsis model
General anesthesia was applied to the rats using keta-
mine HCl (100 mg/kg) and xylazine HCl (10 mg/kg) via
intraperitoneal route. The subjects were immobilized on
the operation table in the supine position and the
abdominal skin was shaved totally, and laparotomy was
carried out through a 2 cm midline incision. Poly micro-
bial sepsis was induced by the CLP technique described
previously [21]. The cecum was isolated through laparot-
omy, and the ascending colon was gently touched down-
ward to fill the cecum with feces. The cecum was ligated
below the ileocecal valve using 3.0 silk thread, and the
ventral side was perforated twice using No.21 gauge nee-
dle to let fecal contents spread into the peritoneum.
Then, the abdomen was closed with two layers continu-
ous suture using 3.0 silk thread. Rats were resuscitated
with normal saline (1 ml/100 g body weight given sub-
cutaneously) at the end of the operation. In the sham
group, the cecum was explored but CLP was not ap-
plied. The rats were monitored in room temperature of
22 °C, with controlled humidity and light and allowed
standard food and drinking water till 12 h after the oper-
ation. All the rats were sacrificed 24 h after the
operation.
Experimental protocol
The rats were randomly subdivided into 4 groups of 7
rats. Group I (Sham group): operative procedure was ap-
plied, but cecal ligation perforation was not performed.
Group II (CLP group): sepsis was induced using the
cecal ligation and perforation (CLP) method. Group III
(Phloretin group): sepsis was induced using the CLP
method and 50 mmol/kg phloretin was administered via
the intraperitoneal route in two equal doses immediately
after surgery and at the post-operative 12th hour and fi-
nally, control group which peritoneally received dimethyl
sulfoxide as phloretin solvent [15, 22].
Blood collection and determination of biochemical
parameters
Blood samples collected through a cardiac puncture,
centrifuged at 1000 g for 5 min and serum was sepa-
rated. The samples were then transferred into Eppendorf
tubes and stored at 4 °C within 1 h after collection for
biochemical assay according to the instructions provided
by the manufacturers.
Serum creatinine concentration was measured using Jaffe
method [21]. The rest of serum was stored at -70 °C for
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further analysis. BUN and creatine phosphokinase (CPK)
were determined by UV method using auto analyzer
(COBAS Integra C111; Roche Diagnostics, Switzerland).
Measurement of serum TNF-α level
Serum level of TNF-α, as an inflammatory cytokine, was
assayed according to the manufacturer’s instruction
using an enzyme-linked immunosorbent assay (ELISA)
kit from BioSource Europe. The concentration of TNF-α
was calculated from the standard curve and results were
presented as pg/ml.
Immunoassay of NF-ĸB P65
To investigate liver NF-ĸB activity, p65 Transcription
Factor Assay kit (Cayman chemical) was employed. NF-
ĸB activity was measured calorimetrically according to
the manufacturer’s instructions. For preparation of hep-
atic cells nuclear fraction, frozen liver tissue was homog-
enized in lysis buffer with 2 % Triton X-100 and
aprotinin, and centrifuged at 1000 g for 5 min. The pel-
let was then resuspended in 5 ml ice-cold 1X Nuclear
extraction PBS/Phosphatase inhibitor solution and cen-
trifuged at 300xg for 5 min at 4 °C, and the aliquot of
the nuclear extract was used for the measurement. Total
proteins were quantified by Lowry’s method (Lowry et
al. 1951). Briefly, 10 μl of samples were added to the ap-
propriate well that contained its relevant complete tran-
scription factor buffer (CTFB). The plate was incubated
overnight at 4 °C, and the wells were washed with 1x
washing buffer five times. Primary antibody was then
added to the appropriate well, and the plate was incu-
bated for 1 h at 37 °C. Subsequently, the horseradish
peroxidase (HRP) linked secondary antibody was added
and the plate was incubated for 30 min at 37 °C. Follow-
ing addition of the substrate, plates were incubated for
45 min at room temperature, the reaction was stopped
and samples were measured spectrophotometerically at
450 nm. Each phosphoprotein absorbance was corrected
by the negative control and was normalized by its rele-
vant NF-ĸB p65 absorbance.
Tissue GSH level
The level of GSH was determined by the method
explained previously by Sedlak and Lindsay [22]. This
assay is based on the production of yellow color when 5,
5-dithionitrobisbenzoic acid (DTNB) is added to com-
pounds containing sulphydryl groups. The liver tissue
was homogenized in 0.02 M EDTA and mixed for 10–
15 min with an equal volume of 10 % TCA. It was then
centrifuged at 10,000 g for 10 min. 1 ml of the super-
natant was mixed with 0.5 ml of Ellman’s reagents
(19.8 mg of DTNB in 100 ml of 0.1 % sodium nitrate)
and 3 ml of phosphate buffer (0.2 M, pH 8.0). The
absorbance was immediately recorded at 412 nm on a
spectrophotometer. Results were expressed as μmol
GSH/g tissue [23].
Histopathological examination
Liver tissues were fixed in a 10 % formalin solution.
They were washed with PBS buffer overnight and were
slowly dehydrated by crossing through the solutions by
enhancing the concentrations of alcohol. Subsequently,
the tissue samples were placed in paraffin and were fixed
in blocks. Then sections with 5-6 μm thickness were ob-
tained from the tissue samples placed on slides. Finally,
slides were stained by hematoxylin-eosin and examined
under a light microscope (Olympus BHX51; Tokyo,
Japan) at X40 magnification.
Statistical analysis
Statistical analysis was performed using a GraphPad
Prism 3.0 (GraphPad Software, San Diego; CA; USA).
Data were evaluated by one-way analysis of variance
(ANOVA) and Tukey’s test was used for pairwise
comparisons. All data were expressed as means ± SEM.
Values of p ≤ 0.05 were considered as statistically
significant.
Results
Blood Urea Nitrogen (BUN)
Our findings showed that cecal ligation and puncture
caused a significant increase in serum BUN level (43.88 ±
1.905 mg/dl) compared with the sham group (26.17 ±
2.303), p < 0.01. Following treatment with phloretin (CLP +
P), serum BUN levels were decreased (31.77 ± 1.514 mg/dl),
in comparison with CLP group (p < 0.01), Fig. 1a.
Serum creatinine level (Scr)
Serum creatinine mildly increased in CLP group (0.670
± 0.017) in comparison with the sham group (0.575 ±
0.027). There were no significant differences in serum
creatinine level between phloretin treated (0.646 ± 0.023)
and untreated control group (p < 0.05), Fig. 1b.
Serum Creatine Phosphokinase (CPK)
The serum CPK level was not changed significantly
when compared to the sham group, Fig. 1c.
Serum TNF-α levels
TNF- α levels were dramatically increased in CLP operated
group (37.63 ± 1.92) when compared to the sham group
(10.69 ± 1.03), p <0.05. This rise was significantly abolished
following phloretin treatment (29.14 ± 2.29) p <0.05, Fig. 2.
Liver NF-ĸB level
The protective effect of phloretin on liver NF-ĸB level is
shown in Fig. 3. In CLP group, the liver NF-ĸB level was
significantly elevated (more than two-fold) in comparison
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with the sham group (p < 0.05), whereas the elevation was
significantly reduced in the phloretin treated group.
Tissue Glutathione (GSH) levels
Sepsis caused a significant decrease (p ≤0.01–p ≤0.0001)
in GSH levels in liver, kidney, heart and lung tissues in
comparison to the sham group. Phloretin treatment
significantly (p <0.05) restored the GSH level (Table 1).
Histopathological findings
Histological examinations were carried out by a pathologist
and pathological events were scored semi-quantitatively.
Slides were stained with hematoxylin-eosin and vascular
change, local necrosis, hepatocytes morphology, presence
and severity of poly morphonuclear leukocytes (PMNL)
were considered in the histopathological sections of the
liver tissue.
Normal sinusoids and hepatocytes were noticed in the
hepatic parenchyma of the sham group, Fig. 4a. Within
sepsis group, serious sinusoidal duct dilation and vascu-
lar obstruction, and damaged hepatocytes with many
cytoplasmic vacuoles were seen. Moreover, increased
number of Kupffer cells and liver dead cells (LDC) were
found, Fig. 4b. Meanwhile, treatment with phloretin
improved sinusoidal duct dilation, vascular blockage,
and hepatocytes morphology. In addition, phloretin
decreased the foam like cells near the lobular central
vein, Fig. 4c.
Discussion
Sepsis is described as a severe and irregular systemic
inflammatory reaction syndrome (SIRS) against infec-
tion, and free oxygen radicals are among important
Fig. 1 a Serum level of BUN in Sham (negative control), CLP (cecal ligation and puncture as a positive control) and CLP + P (CLP rats treated with
Phloretin) in 24 h after sepsis induction by CLP. Data are presented as mean ± SEM. CLP (cecal ligation and puncture) vs. Sham group (****) p < 0.0001,
CLP+ phloretin vs. CLP group (##) p < 0.01. b and c. Serum level of Creatinine and creatinine phosphokinase, respectively (n = 7 per group). Data are
presented as mean ± SEM. CLP (cecal ligation and puncture) vs. Sham group (*) p < 0.05
Fig. 2 Changes in serum tumor necrosis factor-alpha (TNF-α) in CLP
(cecal ligation and puncture) and phloretin treated rats. Results are
expressed as mean ± SEM for 7 rats. CLP (cecal ligation and puncture) vs.
Sham group (***) p< 0.001, CLP+ phloretin vs. CLP group (##) p< 0.01
Fig. 3 ELISA results of NF-ĸB in liver extract. Bars represent the Sham
group NF-ĸB transcription factor as 100 %. CLP (cecal ligation and
puncture) vs. sham group (****) p < 0.0001, CLP+ phloretin vs. CLP
group (##) p < 0.01
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mediators responsible for the inflammatory response.
The objective of the present study was to evaluate the
protective effect of phloretin against sepsis-induced oxi-
dative organ damage using biochemical parameters,
tissue GSH level and histopathological examination of
liver tissue.
CLP caused a sharp increase in serum levels of TNF-α
in comparison to the sham group (p < 0.001). TNF-α is
pro-inflammatory cytokine produced by stimulated
macrophages [24]. In sepsis, cytokines like TNF-α,
interleukin-1 beta (IL-1β) and IL-6 which are released
after infection, play an important role in the inflamma-
tory process [25]. Triggering inflammation by high levels
of TNF-α may lead to tissue damage and, if not treated,
to sepsis or death [26]. Serum levels of TNF-α were sig-
nificantly suppressed following phloretin treatment as
compared to the untreated CLP group (p < 0.001). Phlor-
etin is an effective antioxidant for inhibiting the peroxi-
dation of nitroso anions and lipids, and it has antitumor
functions [27]. In an animal model, it was demonstrated
that phloretin protect hepatocytes against oxidative
stress through the ERK2/Nrf2 pathway and GCL expres-
sion [28]. Moreover, it was observed that phloretin has
significantly decreased levels of NO, TNF-α, PGE2, iNOS
and COX-2 in LPS-stimulated RAW264.7 cells [29].
In CLP group, the liver NF-ĸB transcription factor
level was significantly elevated (more than two-fold) in
comparison to the sham group (p < 0.05). NF-κB is a
protein complex with DNA transcription regulatory ef-
fect. NF-ĸB is a heterodimer and primarily composed of
p50 and p65 subunits [30]. The NF-ĸB p65 subunit is
phosphorylated and translocated into the nucleus to
bind promoter of inflammatory-associated gene and
expression inflammatory cytokines and Mediators [31].
It is activated by multiple signals, including tissue dam-
age, oxidative stress, pro-inflammatory cytokines, and
pathogen associated molecular patterns, that induce
inhibition of kK (IkK) phosphorylation. Stimulated IkK
discharge NF-ĸB from its cytoplasmic retainer, an inhibi-
tor of ĸB, facilitating its translocation to the nucleus.
NF-ĸB binds to distinct DNA sequences to increase
transcription of genes encoding significant inflammatory
mediators [32]. Binding of NF-ĸB to DNA, transcription
of TNF-α and iNOS are obvious in inflammatory
diseases [32–35]. It was observed that phloretin inhib-
ited phosphorylation in MAPK pathways by suppressing
NF-κB p65 proteins nuclear translocation in macro-
phages [29].
Although the exact mechanism of phloretin action
remains unclear, a large body of evidence suggests that
phloretin exhibits anti-oxidant properties and may be
used as an anti-inflammatory agent [29, 36, 37]. Phlore-
tin prevented inflammation process by reducing liver
NF-ĸB level (p < 0.01). It is believed that phloretin is re-
sponsible for NF-ĸB activation mainly via IkK phosphor-
ylation. The IkK phosphorylation inhibits IkK activity
which may lead to ĸB attachment to DNA sequences.
The following gene expression has been documented in
vitro in inflammatory and vascular cells provoked with
LPS, staphylococcal enterotoxin A, TNF-α, or IL-1β, and
Table 1 Tissue glutathione level (μmol/g) in septic rats treated with phloretin
Groups Liver Kidney Lung Heart
Sham 7.08 ± 0.15 5.38 ± 0.09 7.82 ± 0.5 6.38 ± 0.29
CLP 4.87 ± 0.24*** 3.94 ± 0.27*** 6.07 ± 0.14*** 4.94 ± 0.32****
CLP + Phloretin 6.08 ± 0.11### 4.93 ± 0.17## 7.02 ± 0.82## 4.81 ± 0.13##
Data presented as Mean ± SEM of 7 samples. CLP (Cecal Ligation and puncture) compared to the Sham group. (***) p < 0.001, (****) p < 0.0001 and CLP+ phloretin
vs. CLP group (##) p < 0.01, (###) p < 0.001
Fig. 4 Liver tissue sections are shown. a: in the sham group, central vein, normal sinusoids and hepatocytes with regular morphology are seen. b: through
sepsis group, enormous vascular obstruction, extreme cytoplasmic vacuoles (→), sinusoidal duct dilation, damaged hepatocytes and stimulated Kupffer
cells are observed. c: in the sepsis group treated with phloretin, mildly damaged hepatocytes (→), moderate vascular obstruction and sinusoidal duct
dilatation are noted. Hepatic parenchyma slides were stained with hematoxylin-eosin, original magnification: X400
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in vivo in models of inflammatory disease [38]. A rela-
tion between sepsis and NF-ĸB activation has been
reflected in several cell culture and animal studies [38].
Oxidative stress regulates NF-ĸB activation, and the
manifest of such stress has been demonstrated in
sufferers from sepsis. Previously it was reported that
phloretin possess anti-inflammatory properties due to
inhibition of nucleus NF-κB translocation and suppres-
sion of mitogen-activated protein kinase (MAPK) signal-
ing pathway proteins phosphorylation in human
keratinocytes [37, 39]. It is more likely that an increase
in NF-ĸB and, therefore, up-regulation of cytokines, will
happen in these patients [38]. This is in collaboration
with our findings of more than two-fold increase in NF-
ĸB transcription factor levels (P <0.05) which was signifi-
cantly decreased by phloretin treatment (p < 0.001).
Creatinine level was measured 24 h after sepsis induc-
tion and a mild increase in untreated CLP group (0.670
± 0.017) was observed in comparison with the sham
group (0.575 ± 0.027). Creatinine is a byproduct of creat-
ine phosphate in breakdown muscles. Serum creatinine
is an important marker of kidney function which is
excreted unchanged. In addition, there were no signifi-
cant differences in serum creatinine phosphokinase level
between treated and untreated groups level (p < 0.05).
Phloretin significantly decreased BUN in comparison to
the untreated CLP group. BUN is a good marker for
renal damage in cases of decreased Glomerular Filtration
Rate (GFR) (suggestive of renal failure).
There is a relation between oxidative stress and peri-
toneal sepsis [7]. There are several defense mechanisms
against the toxic effects of free oxygen radicals. GSH is a
natural antioxidant defense system which is found in
high concentrations in all cells and in epithelial surface
fluid. GSH shows a protective effect by neutralizing free
radicals and reactive oxygen intermediates [40, 41]. It is
well understood that a wide group of natural products
such as plant polyphenols and flavonoids have anti-
inflammatory and anti oxidative properties [42, 43].
Polyphenols are the most available dietary antioxidants.
A large body of evidence strongly suggests a contribu-
tion of polyphenols to the prevention of life threatening
disease such as cancers, diabetes mellitus, osteoporosis
and cardiovascular [44, 45]. Based on meta-analyses and
associated epidemiological studies, polyphenols as sec-
ondary plants metabolites are considerably involved in
biological defense against ultraviolet radiation or patho-
gens aggression [46–49]. Flavonoid is a general term for
flavanones, flavanols, flavones, chalcones and anthocya-
nins [50]. Beside antioxidant activity, certain polyphenols
possess a potent anticarcinogenic activity through en-
zyme modulation, upregulation of gap junction commu-
nication, gene expression, apoptosis and P-glycoprotein
activation in cell culture and animal models [51–53].
Phloretin treatment was able to protect animals against
sepsis-induced oxidative tissue damage and maintained
GSH levels in hepatic, renal, heart and respiratory
tissues in comparison to the untreated sepsis group (p <
0.01). It was previously demonstrated that phloretin in-
creases GSH level and HO-1 expression in carbon
tetrachloride-induced rat hepatotoxicity [28]. Reduced
glutathione as the main source of sulfhydryl pool is well
known to be a crucial scavenger of free radicals in the
cell [24, 26]. The non-protein sulphydryls binds to a
diverse group of electrophilic radicals and metabolites
[54]. It has been suggested that antioxidants which save
GSH content, may restore the cellular defense mecha-
nisms, inhibit lipid peroxidation and thus provide
cellular protection against the oxidative tissue damage.
Previously it showed that phloretin has biological and
anti-infective activity with beneficial effect on inflamma-
tory bowel diseases (IBD) as well as anti-oxidative char-
actrisitcs and inhibition of Escherichia coli O157:H7 bio-
film formation without harming beneficial commensal E.
coli biofilms [15, 55–58]. In addition, phloretin (24 μM)
May also be involved in lipid peroxidation and oxidative
stress inhibition in cell culture [54].
Erkel et al. showed that dihydrochalcone aglycone
phloretin significantly blocked pro-inflammatory gene
expression and decreased IL-8, IP-10 and NF-ĸB
promoter signal transduction in a dose-dependent
manner. Furthermore, the apple juice critically hinder
the expression of NF-ĸB regulated pro-inflammatory
genes (IL-1β, CXCL9, TNF-α), inflammatory-related
enzymes (CYP3A4, COX-2), and transcription factors
(STAT1, IRF1) in LPS/IFN-γ provoked MonoMac6
cells without significant influence on the expression
of house-keeping genes [37]. Phloretin exhibited anti-
inflammatory effects through decreasing IL-6, IL-8,
intercellular adhesion molecule (ICAM)-1 production
and mRNA expression in TNF-α stimulated HaCaT
human cells [39]. Furthermore, neuroprotective effects
of phloretin has been demonstrated thorough Nrf2
pathway activation and oxidative stress suppression in
rat [36].
Conclusion
The present study evidenced strong anti-oxidant and
anti-inflammatory effects of phloretin against tissue
damage from CLP-induced sepsis, likely caused by free
oxygen radicals. Thus, it will open a new window for the
possibility of clinical application of phloretin in severe
conditions such as sepsis. However, further studies
required to highlight the exact underlying mechanisms
of the observed protective effect. As our knowledge
improves in this field, therapeutic targeting would be
possible in several disorders.
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